LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Organ-on-a-Chip Device Mimics Structure and Function of Human Placental Barrier

By LabMedica International staff writers
Posted on 09 Aug 2016
Image: The flash-drive-sized device contains two layers of human cells that model the interface between mother and fetus. Microfluidic channels on either side of those layers allow studies of how molecules are transported through, or are blocked by, that interface (Photo courtesy of the University of Pennsylvania).
Image: The flash-drive-sized device contains two layers of human cells that model the interface between mother and fetus. Microfluidic channels on either side of those layers allow studies of how molecules are transported through, or are blocked by, that interface (Photo courtesy of the University of Pennsylvania).
A novel lab-on-a-chip device mimics the structure and function of the human placental barrier and allows researchers to carry out in vitro studies on factors influencing fetal development.

During human pregnancy, the fetal circulation is separated from maternal blood in the placenta by two cell layers – the fetal capillary endothelium and placental trophoblast. This placental barrier plays an essential role in fetal development and health by tightly regulating the exchange of endogenous and exogenous materials between the mother and the fetus.

To mimic the characteristic architecture of the human placental barrier, investigators at the University of Pennsylvania (Philadelphia, USA) created on a silicon chip a multilayered microfluidic system that enabled co-culture of human trophoblast cells and human fetal endothelial cells in a physiologically relevant spatial arrangement. The device comprised two parallel microfluidic channels separated by a porous membrane. On one side of those pores, trophoblast cells, which are found at the placental interface with maternal blood, were grown. On the other side were endothelial cells, found on the interior of fetal blood vessels.

The co-culture model was designed to induce progressive fusion of trophoblast cells and to form a syncytialized epithelium that resembled the in vivo syncytiotrophoblast. The system also allowed the cultured trophoblasts to form dense microvilli under dynamic flow conditions and to reconstitute expression and physiological localization of membrane transport proteins, such as glucose transporters (GLUTs), critical to the barrier function of the placenta.

In a proof-of-principle study, the investigators used the "placenta-on-a-chip" device to demonstrate physiological transport of glucose across the artificial maternal-fetal interface. They reported in the May 20, 2016, online edition of the journal Lab on a Chip that the rate of maternal-to-fetal glucose transfer in this system closely approximated that measured in ex vivo perfused human placentas.

"The placenta is arguably the least understood organ in the human body," said senior author Dr. Dongeun Huh, professor of bioengineering at the University of Pennsylvania, "and much remains to be learned about how transport between mother and fetus works at the tissue, cellular, and molecular levels. An isolated whole organ is not an ideal platform for these types of mechanistic studies. "

"The placental cells change over the course of pregnancy," said Dr. Huh. "During pregnancy, the placental trophoblast cells actually fuse with one another to form an interesting tissue called syncytium. The barrier also becomes thinner as the pregnancy progresses, and with our new model we are able to reproduce this change. Eventually, we hope to leverage the unique capabilities of our model to demonstrate the potential of organ-on-a-chip technology as a new strategy to innovate basic and translational research in reproductive biology and medicine."

Related Links:
University of Pennsylvania


Gold Member
Respiratory Syncytial Virus Test
OSOM® RSV Test
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Automated MALDI-TOF MS System
EXS 3000
Gold Member
Immunochromatographic Assay
CRYPTO Cassette

Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more